International Stem Cell Corp. (OTCMKTS:ISCO) CEO Andrey Semechkin bought 200,000 shares of the stock in a transaction on Wednesday, September 14th. The stock was acquired at an average price of $1.75 per share, with a total value of $350,000.00. Following the completion of the acquisition, the chief executive officer now owns 1,221,436 shares of the company’s stock, valued at approximately $2,137,513. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Andrey Semechkin also recently made the following trade(s):

  • On Monday, August 22nd, Andrey Semechkin bought 154,285 shares of International Stem Cell Corp. stock. The stock was acquired at an average price of $1.75 per share, with a total value of $269,998.75.
  • On Wednesday, June 29th, Andrey Semechkin bought 215,000 shares of International Stem Cell Corp. stock. The stock was acquired at an average price of $1.75 per share, with a total value of $376,250.00.

Shares of International Stem Cell Corp. (OTCMKTS:ISCO) opened at 1.80 on Wednesday. The stock’s 50 day moving average price is $1.93 and its 200 day moving average price is $2.64. International Stem Cell Corp. has a 12-month low of $1.50 and a 12-month high of $6.95. The company’s market cap is $5.82 million.

Receive News & Ratings for International Stem Cell Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.